Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma

Journal of Oral Pathology and Medicine

Volumn 39, Issue 3, 2010, Pages 242-249

  Shen, Ling Chang ^a   Chen, Yuk Kwan ^b,c   Hsue, Shue Sang ^d   Shaw, Shyh Yu ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Ameloblastoma; Matrix metalloproteinase 9; Osteonectin; Secreted protein acidic and rich in cysteine

Indexed keywords

CYSTEINE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; OSTEONECTIN;

ADULT; AMELOBLASTOMA; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CLINICAL STUDY; COLUMNAR EPITHELIUM; CYTOPLASM; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; GENETIC CORRELATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULUM CELL; STELLATE CELL; STROMA CELL;

ADOLESCENT; ADULT; AMELOBLASTOMA; COHORT STUDIES; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, SECRETED; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OSTEONECTIN; YOUNG ADULT;

EID: 77249127038     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00862.x     Document Type: Article

References (47)

1. Zemann W, Feichtinger M, Kowatsch E, et al. Extensive ameloblastoma of the jaws: surgical management and immediate reconstruction using microvascular flaps. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 103 : 190 196.
2. Lau SL, Samman N. Recurrence related to treatment modalities of unicystic ameloblastoma: a systematic review. Int J Oral Maxillofac Surg 2006 35 : 681 690.
3. Becelli R, Carboni A, Cerulli G, et al. Mandibular ameloblastoma: analysis of surgical treatment carried out in 60 patients between 1977 and 1998. J Craniofac Surg 2002 13 : 395 400.
4. Gortzak RA, Latief BS, Lekkas C, et al. Growth characteristics of large mandibular ameloblastomas: report of 5 cases with implications for the approach to surgery. Int J Oral Maxillofac Surg 2006 35 : 691 695.
5. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999 274 : 21491 21494.
6. Noel A, Jost M, Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol 2008 19 : 52 60.
7. Pilcher BK, Sudbeck BD, Dumin JA, et al. Collagenase-1 and collagen in epidermal repair. Arch Dermatol Res 1998 290 (Suppl S37 46.
8. Pilcher BK, Dumin JA, Sudbeck BD, et al. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 1997 137 : 1445 1457.
9. Masson V, de la Ballina LR, Munaut C, et al. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J 2005 19 : 234 236.
10. Termine JD, Kleinman HK, Whitson SW, et al. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981 26 : 99 105.
11. Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 2002 14 : 608 616.
12. Clark CJ, Sage EH. A prototypic matricellular protein in the tumor microenvironment-where there's SPARC, there's fire. J Cell Biochem 2008 104 : 721 732.
13. Ledda MF, Adris S, Bravo AI, et al. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med 1997 3 : 171 176.
14. Pinheiro JJ, Freitas VM, Moretti AI, et al. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology 2004 45 : 65 72.
15. Chen JJ, Lin YC, Yao PL, et al. Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 2005 23 : 953 964.
16. Arnold S, Mira E, Muneer S, et al. Forced expression of MMP-9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC. Exp Biol Med 2008 233 : 860 873.
17. Kramer IR, Pindborg JJ, Shear M. The WHO histological typing of odontogenic tumours. A commentary on the Second Edition. Cancer 1992 70 : 2988 2994.
18. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981 29 : 577 580.
19. Krajewska M, Fenoglio-Preiser CM, Krajewski S, et al. Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am J Pathol 1996 149 : 1449 1457.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977 33 : 159 174.
21. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001 17 : 463 516.
22. Okada Y, Gonoji Y, Nakanishi I, et al. Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium. Virchows Arch B Cell Pathol Incl Mol Pathol 1990 59 : 305 312.
23. Kubota T, Nomura T, Takahashi T, et al. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue. Arch Oral Biol 1996 41 : 253 262.
24. Liotta LA, Stetler-Stevenson WG. Metalloproteinases and cancer invasion. Semin Cancer Biol 1990 1 : 99 106.
25. Chiang YY, Tsai MH, Lin TY, et al. Expression profile of metastasis-related genes in invasive oral cancers. Histol Histopathol 2008 23 : 1213 1222.
26. Yang SF, Yang WE, Kuo WH, et al. Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Arch Oral Biol 2008 53 : 287 294.
27. Kerrigan JJ, Mansell JP, Sandy JR. Matrix turnover. J Orthod 2000 27 : 227 233.
28. Manenti L, Paganoni P, Floriani I, et al. Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma. Eur J Cancer 2003 39 : 1948 1956. (Pubitemid 37311193)
29. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005 436 : 518 524.
30. Kumamoto H, Yamauchi K, Yoshida M, et al. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas. J Oral Pathol Med 2003 32 : 114 120.
31. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005 438 : 820 827.
32. ++-binding protein SPARC (osteonectin) revealed by in situ hybridization. J Cell Biol 1987 105 : 473 482.
33. Reichert T, Störkel S, Becker K, et al. The role of osteonectin in human tooth development: an immunohistological study. Calcif Tissue Int 1992 50 : 468 472.
34. Chlenski A, Liu S, Crawford SE, et al. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res 2002 62 : 7357 7363.
35. Tremble PM, Lane TF, Sage EH, et al. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 1993 121 : 1433 1444.
36. Shankavaram UT, DeWitt DL, Funk SE, et al. Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 1997 173 : 327 334.
37. Gilles C, Bassuk JA, Pulyaeva H, et al. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res 1998 58 : 5529 5536.
38. Kunigal S, Gondi CS, Gujrati M, et al. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA. Int J Oncol 2006 29 : 1349 1357.
39. Sasaki T, Göhring W, Mann K, et al. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem 1997 272 : 9237 9243.
40. Kumamoto H, Ohki K, Ooya K. Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas. J Oral Pathol Med 2002 31 : 28 34.
41. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997 18 : 4 25.
42. Kato Y, Lewalle JM, Baba Y, et al. Induction of SPARC by VEGF in human vascular endothelial cells. Biochem Biophys Res Commun 2001 287 : 422 426.
43. Chantrain CF, Shimada H, Jodele S, et al. Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res 2004 64 : 1675 1686.
44. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002 109 : 625 637.
45. Framson PE, Sage EH. SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 2004 92 : 679 690.
46. Busch E, Hohenester E, Timpl R, et al. Calcium affinity, cooperativity, and domain interactions of extracellular EF-hands present in BM-40. J Biol Chem 2000 275 : 25508 25515. (Pubitemid 30687053)
47. Ikebe T, Shinohara M, Takeuchi H, et al. Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 1999 17 : 315 323.